These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7408402

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The stereoisomers quinine and quinidine exhibit a marked stereoselectivity in the inhibition of hepatobiliary transport of cardiac glycosides.
    Hedman A, Meijer DK.
    J Hepatol; 1998 Feb; 28(2):240-9. PubMed ID: 9514537
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine.
    Hedman A, Angelin B, Arvidsson A, Dahlqvist R, Nilsson B.
    Clin Pharmacol Ther; 1990 Jan; 47(1):20-6. PubMed ID: 2295215
    [Abstract] [Full Text] [Related]

  • 5. Digoxin-quinidine-spironolactone interaction.
    Fenster PE, Hager WD, Goodman MM.
    Clin Pharmacol Ther; 1984 Jul; 36(1):70-3. PubMed ID: 6734052
    [Abstract] [Full Text] [Related]

  • 6. Digoxin-quinidine interaction in patients with chronic renal failure.
    Fenster PE, Hager WD, Perrier D, Powell JR, Graves PE, Michael UF.
    Circulation; 1982 Dec; 66(6):1277-80. PubMed ID: 7139903
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?
    Rameis H.
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):145-53. PubMed ID: 3997300
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.
    Hedman A, Angelin B, Arvidsson A, Dahlqvist R.
    Eur J Clin Pharmacol; 1992 Mar; 42(5):481-5. PubMed ID: 1606994
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Digoxin-quinidine interaction Pharmacokinetic evaluation.
    Hager WD, Fenster P, Mayersohn M, Perrier D, Graves P, Marcus FI, Goldman S.
    N Engl J Med; 1979 May 31; 300(22):1238-41. PubMed ID: 431681
    [Abstract] [Full Text] [Related]

  • 15. Acceleration of digoxin clearance by activated charcoal.
    Lalonde RL, Deshpande R, Hamilton PP, McLean WM, Greenway DC.
    Clin Pharmacol Ther; 1985 Apr 31; 37(4):367-71. PubMed ID: 3978996
    [Abstract] [Full Text] [Related]

  • 16. Effect of alprazolam on digoxin kinetics and creatinine clearance.
    Ochs HR, Greenblatt DJ, Verburg-Ochs B.
    Clin Pharmacol Ther; 1985 Nov 31; 38(5):595-8. PubMed ID: 2865030
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stereoselective inhibition by the diastereomers quinidine and quinine of uptake of cardiac glycosides into isolated rat hepatocytes.
    Hedman A, Meijer DK.
    J Pharm Sci; 1998 Apr 31; 87(4):457-61. PubMed ID: 9548899
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Digoxin-verapamil interaction.
    Pedersen KE, Dorph-Pedersen A, Hvidt S, Klitgaard NA, Nielsen-Kudsk F.
    Clin Pharmacol Ther; 1981 Sep 31; 30(3):311-6. PubMed ID: 7273594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.